Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Diabetes Research and Clinical Practice
|
December 13, 2022
Impact of cumulative hyperglycemic burden on the pancreatic cancer risk: A nationwide cohort study
Dong-Hoe Koo, Kyungdo Han, Cheol-Young Park
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2019
The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study
Dong-Hoe Koo, Kyung-Do Han, Cheol-Young Park
Journal of Diabetes Investigation
|
November 30, 2025
Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study
Dong-Hoe Koo, Jin-Hyung Jung, Kyungdo Han, et al.
Acta Diabetologica
|
August 18, 2019
Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
Dong-Hoe Koo, Kyung-Do Han, Hong Joo Kim, et al.
Journal of Clinical Epidemiology
|
February 28, 2017
The significance of the trial outcome was associated with publication rate and time to publication
Seung Yeon Song, Dong-Hoe Koo, Sun-Young Jung, et al.
Annals of Hematology
|
January 3, 2025
Risk of malignant lymphoma in patients with previous tuberculosis infection: a cohort study
Yun-Gyoo Lee, Dayeon Seo, Hyun-Il Gil, et al.
Plos One
|
July 5, 2012
Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study
Dong Hoe Koo, Cheol-Young Park, Eun Sook Lee, et al.
World Journal of Gastroenterology
|
January 24, 2022
New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, et al.
Journal of Korean Medical Science
|
December 8, 2011
Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy
Sukjoong Oh, Dong Hoe Koo, Cheolwon Suh, et al.
Cancer Research and Treatment
|
February 12, 2025
Significant Dissatisfaction with the Anachronistic System: A Survey on The Experience of Application for Off-Label Use of Anti-Cancer Drugs by Korean Society of Medical Oncology
Jae Lyun Lee, Dong-Hoe Koo, Young-Woong Won, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Diabetes Research and Clinical Practice
|
December 13, 2022
Impact of cumulative hyperglycemic burden on the pancreatic cancer risk: A nationwide cohort study
Dong-Hoe Koo, Kyungdo Han, Cheol-Young Park
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2019
The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study
Dong-Hoe Koo, Kyung-Do Han, Cheol-Young Park
Journal of Diabetes Investigation
|
November 30, 2025
Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study
Dong-Hoe Koo, Jin-Hyung Jung, Kyungdo Han, et al.
Acta Diabetologica
|
August 18, 2019
Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
Dong-Hoe Koo, Kyung-Do Han, Hong Joo Kim, et al.
Journal of Clinical Epidemiology
|
February 28, 2017
The significance of the trial outcome was associated with publication rate and time to publication
Seung Yeon Song, Dong-Hoe Koo, Sun-Young Jung, et al.
Annals of Hematology
|
January 3, 2025
Risk of malignant lymphoma in patients with previous tuberculosis infection: a cohort study
Yun-Gyoo Lee, Dayeon Seo, Hyun-Il Gil, et al.
Plos One
|
July 5, 2012
Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study
Dong Hoe Koo, Cheol-Young Park, Eun Sook Lee, et al.
World Journal of Gastroenterology
|
January 24, 2022
New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, et al.
Journal of Korean Medical Science
|
December 8, 2011
Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy
Sukjoong Oh, Dong Hoe Koo, Cheolwon Suh, et al.
Cancer Research and Treatment
|
February 12, 2025
Significant Dissatisfaction with the Anachronistic System: A Survey on The Experience of Application for Off-Label Use of Anti-Cancer Drugs by Korean Society of Medical Oncology
Jae Lyun Lee, Dong-Hoe Koo, Young-Woong Won, et al.
Page
of 8